Genes, calcium and modifying factors in hypertrophic cardiomyopathy

Clinical and Experimental Pharmacology & Physiology
Tatiana TsoutsmanChristopher Semsarian


1. Familial hypertrophic cardiomyopathy (FHC) is a primary disorder of the myocardium characterized by remarkable diversity in clinical presentations, ranging from no symptoms to severe heart failure and sudden cardiac death. 2. Over the past 15 years, at least 11 genes have been identified, defects of which cause FHC. Most of these genes encode proteins that comprise the basic contractile unit of the heart (i.e. the sarcomere). 3. Genetic studies are now beginning to have a major impact on the diagnosis in FHC, as well as in guiding treatment and preventative strategies. Although much is known about which genes cause disease, relatively little is known about the molecular steps leading from the gene defect to the clinical phenotype and what factors modify the expression of the mutant genes. 4. Concurrent studies in cell culture and animal models of FHC are now beginning to shed light on the signalling pathways involved in FHC and the role of both environmental and genetic modifying factors. Calcium dysregulation appears to be important in the pathogenesis of FHC. 5. Understanding these basic molecular mechanisms will ultimately improve our knowledge of the basic biology of heart muscle function and will therefore provide new a...Continue Reading


Apr 18, 1996·The New England Journal of Medicine·R R Liberthson
May 3, 1996·Science·A A Geisterfer-LowranceJ G Seidman
Jul 17, 1996·JAMA : the Journal of the American Medical Association·B J MaronF O Mueller
Feb 15, 1997·The Journal of Clinical Investigation·C I BerulM E Mendelsohn
Mar 13, 1997·The New England Journal of Medicine·P SpiritoB J Maron
Oct 14, 1998·The Journal of Clinical Investigation·Q YangJ Robbins
Nov 5, 1999·The Journal of Clinical Investigation·B K McConnellD H Fischman
Dec 22, 1999·The Journal of Clinical Investigation·A J MarianR Roberts
Mar 7, 2001·Circulation Research·B K McConnellJ G Seidman
Nov 16, 2001·Journal of Molecular and Cellular Cardiology·C SemsarianJ G Seidman
May 17, 2002·Current Opinion in Cardiology·A J Marian
Mar 20, 2003·Cell Research·Man-Wei ChungChristopher Semsarian
Dec 9, 2003·Trends in Biochemical Sciences·Xander H T Wehrens, Andrew R Marks
Jan 30, 2004·The Medical Journal of Australia·Alessandra DoolanChristopher Semsarian
Dec 15, 2005·Heart, Lung & Circulation·Alessandra DoolanChristopher Semsarian

❮ Previous
Next ❯


Sep 22, 2007·Current Heart Failure Reports·Eric M SnyderBruce D Johnson
Nov 19, 2011·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Constantinos O'MahonyPerry Elliott
Feb 22, 2012·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Michelle Michels
Sep 3, 2008·Clinical and Experimental Pharmacology & Physiology·Tatiana TsoutsmanChristopher Semsarian
Sep 11, 2009·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Theano PapavassiliuMartin Borggrefe
Jul 25, 2012·Current Cardiology Reports·Katy E Bockstall, Mark S Link
Oct 8, 2015·Clinical and Experimental Pharmacology & Physiology·Wei-Wen LimDavid A Saint
Jun 17, 2008·Trends in Cardiovascular Medicine·Massimo BuvoliRob Knight
Dec 26, 2006·Heart, Lung & Circulation·Christopher Semsarian, UNKNOWN CSANZ Cardiovascular Genetics Working Group
Jan 4, 2007·Internal Medicine Journal·J Ingles, C Semsarian
Feb 21, 2007·Clinical Genetics·S KumarUNKNOWN Lymphoedema Consortium
Jan 19, 2010·Journal of Molecular and Cellular Cardiology·Marco L AlvesBeata M Wolska
Sep 8, 2010·The Journal of International Medical Research·D D ZhengW P Jiang
Jan 16, 2009·Therapeutic Advances in Cardiovascular Disease·Rhian Shephard, Christopher Semsarian
Dec 25, 2009·Circulation. Cardiovascular Genetics·Matthew Kelly, Christopher Semsarian
Dec 22, 2007·Neonatology·Afif F El-Khuffash, Eleanor J Molloy
Jan 27, 2019·Expert Opinion on Biological Therapy·Wenbin LiangDarryl R Davis
Aug 25, 2018·Cell & Bioscience·Khampaseuth ThapaRangaprasad Sarangarajan

❮ Previous
Next ❯

Related Concepts

Related Feeds


Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.